New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 7, 2012
16:38 EDTDIS, ABT, VRTX, CECO, CTSH, TPXOn The Fly: Closing Wrap
Stocks on Wall Street were mixed, as investors had a muted reaction to the anti-austerity backlash evidenced in two elections in Europe. Stock futures pointed to a lower open throughout the pre-market trading session but moved off their low prior to the opening bell. The futures action led to a lower but stable open with the market essentially hitting its lows soon after the open. The market began to drift off its lows after the first hour of trading and by midday made it back to positive ground. The market continued to drift for most the remainder of the session until a downturn into the close pushed the S&P and Nasdaq back down to finish the day near the flat line... ECONOMIC EVENTS: In the U.S., consumer credit increased by $21.36B in March, versus expectations of an increase of $9.8B. In Europe, Francois Hollande defeated Nicolas Sarkozy in France's presidential election and voting in Greece’s general election showed a dramatic swing toward anti-austerity groups and away from the pro-Europe parties... COMPANY NEWS: Disney's (DIS) "The Avengers" set U.S. records with its $200M opening weekend, powering the company's shares 2% higher... Abbott Labs (ABT) announced it reached a settlement and will pay $1.6B in connection with its marketing of Depakote... MAJOR MOVERS: Among the notable gainers were Vertex Pharma (VRTX), up $20.71, or 55.36%, to $58.12, amid at least three upgrades and a number of price target increases after the company reported interim data from a Phase 2 study of a combination therapy for certain cystic fibrosis patients, and Career Education (CECO), up 56c, or 8.70%, to $7.00, after the Accrediting Council for Independent Colleges and Schools removed its show-cause directive on all 71 Career Education campuses accredited by the body and the company said four of its campuses were placed on probation. Noteworthy losers included Cognizant (CTSH), down $13.35, or 19.16%, to $56.31, after the company's earnings beat consensus but it said its revising its guidance to be more conservative after seeing slower-than-expected acceleration in demand, and Tempur-Pedic (TPX), down $8.42, or 14.85%, to $48.29, as Raymond James said in a note to investors that the company will offer a discount on one of its most profitable mattresses, the Cloud Supreme, which the firm said was unusual for the company... INDICES: The Dow lost 29.74, or 0.23%, to 13,008.53; the Nasdaq rose 1.42, or 0.05%, to 2,957.76; and the S&P 500 added 0.48, or 0.04%, to 1,369.58.
News For DIS;ABT;VRTX;CECO;CTSH;TPX From The Last 14 Days
Check below for free stories on DIS;ABT;VRTX;CECO;CTSH;TPX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 15, 2014
08:42 EDTCTSHCognizant says TriZetto should not be dilutive to long-term revenue growth
Subscribe for More Information
08:25 EDTCTSHCognizant says does not expect added large scale M&A in 'foreseeable future'
The company said it will continue to look at "tuck-in" acquisitions, but does not see another large M&A deal until this integration is completed and "well under our belt." Cognizant says will continue relying on share repurchase as vehicle for return of cash to shareholders. Cognizant says its capital allocation model remains intact following its acquisition of TriZetto.
08:21 EDTCTSHCognizant says TriZetto acquisition about revenue growth, not cost synergies
Subscribe for More Information
07:45 EDTABTCardiovascular Research Foundation to hold a conference
Transcatheter Cardiovascular Therapeutics: TCT 2014 to be held in Washington, D.C. on September 13-17 with some presentations being webcasted. Webcast Link
07:29 EDTDISSony's 'No Good Deed' tops weekend box office, WSJ reports
Subscribe for More Information
06:23 EDTCTSHFunds advised by Apax Partners agree to sell stake in TriZetto to Cognizant
Funds advised by Apax Partners announced that they have agreed to sell their majority ownership stake in the TriZetto. TriZetto, a provider of world-class healthcare information technology and service solutions, will be sold to Cognizant Technology Solutions for $2.7B in cash, subject to customary adjustments. TriZetto develops, licenses and manages solutions for healthcare payers and providers, providing software and services to approximately 350 health plans helping to increase administrative efficiency, improve the cost and quality of care and succeed in the retail market. Additionally, the company provides revenue-cycle management software solutions to nearly 245,000 doctors and other healthcare providers.
06:18 EDTCTSHCognizant to host conference call
Subscribe for More Information
06:06 EDTCTSHCognizant agrees to acquire TriZetto for $2.7B
Subscribe for More Information
06:01 EDTCTSHCognizant to acquire Trizetto for $2.7B in cash, CNBC reports
Cognizant is going to acquire privately held Trizetto for $2.7B in cash, CNBC's Andrew Ross Sorkin reports, citing sources.
September 14, 2014
13:30 EDTABTAbbott announces positive one-year clinical results from ABSORB II
Subscribe for More Information
September 12, 2014
14:50 EDTDISDisney confirms plans for 'Frozen' attraction at Disney World
Subscribe for More Information
September 11, 2014
13:41 EDTABTAbbott announces new $3B share repurchase program
Subscribe for More Information
September 10, 2014
13:48 EDTDISDisney CFO says digital ads growing 'much faster' than tv advertising
Subscribe for More Information
13:11 EDTDISDisney CFO says Maker integration going well
Subscribe for More Information
09:27 EDTVRTXVertex shares likely to advance further, says RBC Capital
Subscribe for More Information
September 9, 2014
14:54 EDTDISApple announces Apple Pay
Subscribe for More Information
13:58 EDTDISStarbucks, Groupon, OpenTable apps among those to integrate Apple Pay
Subscribe for More Information
11:47 EDTVRTXStocks with call strike movement; FSLR VRTX
First Solar (FSLR) March 80 call option implied volatility increased 2% to 42, Vertex (VRTX) January 105 call option implied volatility increased 6% to 41 according to IVolatility.
06:42 EDTABTLew expects to make decision on combating inversion deals soon, NY Times reports
Subscribe for More Information
September 8, 2014
11:05 EDTVRTXOptions with increasing implied volatility
Options with increasing implied volatility: NPSP GILD VNET AVNR GTAT YHOO RHT VRTX SDRL COV MYL
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use